Clindamycin palmitate
- Level
- Commodity
- Parent
- 51283000
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51283004This classification denotes a lincosamide antibiotic with the molecular formula C34H63ClN2O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C501Z28AFG, chemically known as methyl (2s-trans)-7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-l-threo-alpha-d-galacto-octopyranoside, monopalmitate (ester) but more generally known as clindamycin palmitate, which bears US NIH Compound Identifier 83855. Most nations, for tariff and trade purposes, schedule clindamycin palmitate under HS 29419000 and SITC 54139. As of Q4 2014, CLINDAMYCIN PALMITATE remains US FDA's Preferred Term for this commodity. SMILES: CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@H]([C@H](O[C@@H]1SC)[C@@H]([C@H](C)CL)NC(=O)[C@@H]2C[C@H](CN2C)CCC)O)O.
Same parent
Under 51283000 · 7Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.